What is it about?
It is a letter to the editor.
Featured Image
Photo by CDC on Unsplash
Why is it important?
It raised several questions with respect to the revelant article: Jiménez D, Agustí A, Tabernero E, et al; SLICE Trial Group. Effect of a pulmonary embolism diagnostic strategy on clinical outcomes in patients hospitalized for COPD exacerbation: a randomized clinical trial.JAMA. 2021;326(13):1277-1285.
Perspectives
In the SLICE trial,implementation of an active strategy for the diagnosis of pulmonary embolism (PE) did not significantly improve a composite health outcome compared with usual care alone among patients hospitalized for an exacerbation of chronic obstructive pulmonary disease (COPD). There are some concerns about this study.
Dr Wei Xiong
Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Read the Original
This page is a summary of: A Pulmonary Embolism Diagnostic Strategy in Patients Hospitalized for COPD Exacerbation, JAMA, January 2022, American Medical Association (AMA),
DOI: 10.1001/jama.2021.21709.
You can read the full text:
Contributors
The following have contributed to this page
